Royan Institute achieves global milestone in regenerative medicine with WhartoCell
TEHRAN – Iran has taken a major step forward in regenerative medicine with the approval of WhartoCell, an allogeneic stem cell therapy developed by researchers at Royan Institute to treat osteoarthritis.